Impiricus
PrivateLast Round
Seed
Apr 26, 2022
Est. Valuation
$5.5M
Total Funding Raised
$3.49M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Impiricus is a healthcare technology company that provides an AI-powered engagement platform to ethically connect physicians with pharmaceutical company resources.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Enterprise Communication, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Impiricus Comparables
Compare Impiricus with similar companies based on industry and business-model similarity.
Impiricus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 26, 2022 | ||||
| Pre Seed | Apr 2, 2021 |
Key People
Founding team and executive leadership
Impiricus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlanta Tech Village | Pre Seed |
| Surface Ventures | Seed |
| FCA Venture Partners | Seed |
| Johnson Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 17% QoQ, from 174 to 204 employees.
- Jul 16, 2026
Grew 21% QoQ, adding 34 employees.
Recent news
Latest coverage and updates
- integrates_withSep 8, 2026
Impiricus integrated with Medvantx on Sep 8th '26.
- launchesAug 25, 2026
Impiricus launched QPharma integration on Aug 25th '26.
- recognized_asAug 11, 2026
Impiricus recognized as No. 14 on the 2026 Inc. 5000 list on Aug 11th '26.
- recognized_asAug 11, 2026
Impiricus recognized as #1 fastest-growing company in North America on the 2025 Technology Fast 500(TM) on Jul 1st '25.
Impiricus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Impiricus's valuation, stock price, and market status.
Is Impiricus a public or private company?
Impiricus is a private company.
What is the current stock price of Impiricus?
Impiricus is a private company with no public stock price. No recent secondary market data is available.
How much is Impiricus worth (valuation)?
Valuation information for Impiricus is not publicly available.
Can I buy Impiricus stock?
Impiricus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Impiricus's last funding round?
Impiricus's most recent funding round was Seed on April 26, 2022.
Who are the main investors in Impiricus?
Key investors in Impiricus include FCA Venture Partners.
Will Impiricus IPO soon?
No public IPO plans have been announced for Impiricus.
How can I track Impiricus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Impiricus's secondary market activity and sign up for updates.